Lorraine Registry of Multiple Sclerosis

NCT02883335 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2023-02-08

No results posted yet for this study

Summary

The RelSEP aims to register exhaustively every new case of multiple sclerosis (MS) occuring in Lorraine a French region, and follow up on them for an indefinite duration, registering disease evolution and intercurrent events.

Conditions

Interventions

OTHER

Observational registry

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • University of Lorraine

    collaborator OTHER
  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Francis Guillemin, MD, PHD · CHRU Nancy

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883335 on ClinicalTrials.gov